JW Pharmaceutical surges 55.48% as hair-loss stocks follow Wall Street interest

Verifying
  • JW Pharmaceutical, Hyundai Pharm and other domestic hair-loss stocks gained after U.S. treatment news.
  • JW Pharmaceutical rose 55.48% over the past week, leading the named companies.
  • Veradermics gained approximately 500% since February, while Appcyte more than doubled this year.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.